Liquid biopsy for the assessment of adrenal cancer heterogeneity: where do we stand?

go back to reference A. Marusyk, K. Polyak, Tumor heterogeneity: causes and consequences. Biochim. Biophys. Acta 1805, 105–117 (2010). https://doi.org/10.1016/J.BBCAN.2009.11.002CrossRefPubMed A. Marusyk, K. Polyak, Tumor heterogeneity: causes and consequences. Biochim. Biophys. Acta 1805, 105–117 (2010). https://​doi.​org/​10.​1016/​J.​BBCAN.​2009.​11.​002CrossRefPubMed

go back to reference M. Shackleton, E. Quintana, E.R. Fearon, S.J. Morrison, Heterogeneity in cancer: cancer stem cells versus clonal evolution. Cell 138, 822–829 (2009). https://doi.org/10.1016/J.CELL.2009.08.017CrossRefPubMed M. Shackleton, E. Quintana, E.R. Fearon, S.J. Morrison, Heterogeneity in cancer: cancer stem cells versus clonal evolution. Cell 138, 822–829 (2009). https://​doi.​org/​10.​1016/​J.​CELL.​2009.​08.​017CrossRefPubMed

go back to reference N. McGranahan, C. Swanton, Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future. Cell 168, 613–628 (2017). https://doi.org/10.1016/J.CELL.2017.01.018CrossRefPubMed N. McGranahan, C. Swanton, Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future. Cell 168, 613–628 (2017). https://​doi.​org/​10.​1016/​J.​CELL.​2017.​01.​018CrossRefPubMed

go back to reference S.K. Gara, J. Lack, L. Zhang, E. Harris, M. Cam, E. Kebebew, Metastatic adrenocortical carcinoma displays higher mutation rate and tumor heterogeneity than primary tumors. Nat.Commun. 9, (2018). https://doi.org/10.1038/S41467-018-06366-Z S.K. Gara, J. Lack, L. Zhang, E. Harris, M. Cam, E. Kebebew, Metastatic adrenocortical carcinoma displays higher mutation rate and tumor heterogeneity than primary tumors. Nat.Commun. 9, (2018). https://​doi.​org/​10.​1038/​S41467-018-06366-Z

go back to reference S.L. Carter, A.C. Eklund, I.S. Kohane, L.N. Harris, Z. Szallasi, A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers. Nat. Genet. 38, 1043–1048 (2006). https://doi.org/10.1038/NG1861CrossRefPubMed S.L. Carter, A.C. Eklund, I.S. Kohane, L.N. Harris, Z. Szallasi, A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers. Nat. Genet. 38, 1043–1048 (2006). https://​doi.​org/​10.​1038/​NG1861CrossRefPubMed

go back to reference S. Popat, R. Hubner, R.S. Houlston, Systematic review of microsatellite instability and colorectal cancer prognosis. J. Clin. Oncol. 23, 609–618 (2005). https://doi.org/10.1200/JCO.2005.01.086CrossRefPubMed S. Popat, R. Hubner, R.S. Houlston, Systematic review of microsatellite instability and colorectal cancer prognosis. J. Clin. Oncol. 23, 609–618 (2005). https://​doi.​org/​10.​1200/​JCO.​2005.​01.​086CrossRefPubMed

go back to reference B.E. Johnson, T. Mazor, C. Hong, M. Barnes, K. Aihara, C.Y. McLean, S.D. Fouse, S. Yamamoto, H. Ueda, K. Tatsuno, S. Asthana, L.E. Jalbert, S.J. Nelson, A.W. Bollen, W.C. Gustafson, E. Charron, W.A. Weiss, I.V. Smirnov, J.S. Song, A.B. Olshen, S. Cha, Y. Zhao, R.A. Moore, A.J. Mungall, S.J.M. Jones, M. Hirst, M.A. Marra, N. Saito, H. Aburatani, A. Mukasa, M.S. Berger, S.M. Chang, B.S. Taylor, J.F. Costello, Mutational analysis reveals the origin and therapy-driven evolution of recurrent glioma. Science 343, 189–193 (2014). https://doi.org/10.1126/SCIENCE.1239947CrossRefPubMed B.E. Johnson, T. Mazor, C. Hong, M. Barnes, K. Aihara, C.Y. McLean, S.D. Fouse, S. Yamamoto, H. Ueda, K. Tatsuno, S. Asthana, L.E. Jalbert, S.J. Nelson, A.W. Bollen, W.C. Gustafson, E. Charron, W.A. Weiss, I.V. Smirnov, J.S. Song, A.B. Olshen, S. Cha, Y. Zhao, R.A. Moore, A.J. Mungall, S.J.M. Jones, M. Hirst, M.A. Marra, N. Saito, H. Aburatani, A. Mukasa, M.S. Berger, S.M. Chang, B.S. Taylor, J.F. Costello, Mutational analysis reveals the origin and therapy-driven evolution of recurrent glioma. Science 343, 189–193 (2014). https://​doi.​org/​10.​1126/​SCIENCE.​1239947CrossRefPubMed

go back to reference P.C. Nowell, The clonal evolution of tumor cell populations. Science 194, 23–28 (1976). https://doi.org/10.1126/SCIENCE.959840CrossRefPubMed P.C. Nowell, The clonal evolution of tumor cell populations. Science 194, 23–28 (1976). https://​doi.​org/​10.​1126/​SCIENCE.​959840CrossRefPubMed

go back to reference M. Gerlinger, A.J. Rowan, S. Horswell, J. Larkin, D. Endesfelder, E. Gronroos, P. Martinez, N. Matthews, A. Stewart, P. Tarpey, I. Varela, B. Phillimore, S. Begum, N.Q. McDonald, A. Butler, D. Jones, K. Raine, C. Latimer, C.R. Santos, M. Nohadani, A.C. Eklund, B. Spencer-Dene, G. Clark, L. Pickering, G. Stamp, M. Gore, Z. Szallasi, J. Downward, P.A. Futreal, C. Swanton, Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N. Engl. J. Med. 366, 883–892 (2012). https://doi.org/10.1056/NEJMOA1113205CrossRefPubMedPubMedCentral M. Gerlinger, A.J. Rowan, S. Horswell, J. Larkin, D. Endesfelder, E. Gronroos, P. Martinez, N. Matthews, A. Stewart, P. Tarpey, I. Varela, B. Phillimore, S. Begum, N.Q. McDonald, A. Butler, D. Jones, K. Raine, C. Latimer, C.R. Santos, M. Nohadani, A.C. Eklund, B. Spencer-Dene, G. Clark, L. Pickering, G. Stamp, M. Gore, Z. Szallasi, J. Downward, P.A. Futreal, C. Swanton, Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N. Engl. J. Med. 366, 883–892 (2012). https://​doi.​org/​10.​1056/​NEJMOA1113205CrossRefPubMedPubMedCentral

go back to reference T. Wu, Y. Dai, Tumor microenvironment and therapeutic response. Cancer Lett. 387, 61–68 (2017). https://doi.org/10.1016/J.CANLET.2016.01.043CrossRefPubMed T. Wu, Y. Dai, Tumor microenvironment and therapeutic response. Cancer Lett. 387, 61–68 (2017). https://​doi.​org/​10.​1016/​J.​CANLET.​2016.​01.​043CrossRefPubMed

go back to reference D.C. Hinshaw, L.A. Shevde, The Tumor Microenvironment Innately Modulates Cancer Progression. Cancer Res. 79, 4557–4567 (2019). https://doi.org/10.1158/0008-5472.CAN-18-3962CrossRefPubMedPubMedCentral D.C. Hinshaw, L.A. Shevde, The Tumor Microenvironment Innately Modulates Cancer Progression. Cancer Res. 79, 4557–4567 (2019). https://​doi.​org/​10.​1158/​0008-5472.​CAN-18-3962CrossRefPubMedPubMedCentral

go back to reference G.P. Dunn, L.J. Old, R.D. Schreiber, The immunobiology of cancer immunosurveillance and immunoediting. Immunity 21, 137–148 (2004). https://doi.org/10.1016/J.IMMUNI.2004.07.017CrossRefPubMed G.P. Dunn, L.J. Old, R.D. Schreiber, The immunobiology of cancer immunosurveillance and immunoediting. Immunity 21, 137–148 (2004). https://​doi.​org/​10.​1016/​J.​IMMUNI.​2004.​07.​017CrossRefPubMed

go back to reference J.S. O’Donnell, M.W.L. Teng, M.J. Smyth, Cancer immunoediting and resistance to T cell-based immunotherapy. Nat. Rev. Clin. Oncol 16, 151–167 (2019). https://doi.org/10.1038/S41571-018-0142-8CrossRefPubMed J.S. O’Donnell, M.W.L. Teng, M.J. Smyth, Cancer immunoediting and resistance to T cell-based immunotherapy. Nat. Rev. Clin. Oncol 16, 151–167 (2019). https://​doi.​org/​10.​1038/​S41571-018-0142-8CrossRefPubMed

go back to reference I. Dagogo-Jack, A.T. Shaw, Tumour heterogeneity and resistance to cancer therapies. Nat. Rev. Clin. Oncol. 15, 81–94 (2018). https://doi.org/10.1038/NRCLINONC.2017.166CrossRefPubMed I. Dagogo-Jack, A.T. Shaw, Tumour heterogeneity and resistance to cancer therapies. Nat. Rev. Clin. Oncol. 15, 81–94 (2018). https://​doi.​org/​10.​1038/​NRCLINONC.​2017.​166CrossRefPubMed

go back to reference K. Onidani, H. Shoji, T. Kakizaki, S. Yoshimoto, S. Okaya, N. Miura, S. Sekikawa, K. Furuta, C.T. Lim, T. Shibahara, N. Boku, K. Kato, K. Honda, Monitoring of cancer patients via next-generation sequencing of patient-derived circulating tumor cells and tumor DNA. Cancer Sci. 110, 2590–2599 (2019). https://doi.org/10.1111/CAS.14092CrossRefPubMedPubMedCentral K. Onidani, H. Shoji, T. Kakizaki, S. Yoshimoto, S. Okaya, N. Miura, S. Sekikawa, K. Furuta, C.T. Lim, T. Shibahara, N. Boku, K. Kato, K. Honda, Monitoring of cancer patients via next-generation sequencing of patient-derived circulating tumor cells and tumor DNA. Cancer Sci. 110, 2590–2599 (2019). https://​doi.​org/​10.​1111/​CAS.​14092CrossRefPubMedPubMedCentral

go back to reference G. Arnaldi, M. Boscaro, Adrenal incidentaloma. Best Pract. Res. Clin. Endocrinol. Metab. 26, 405–419 (2012). https://doi.org/10.1016/j.beem.2011.12.006CrossRefPubMed G. Arnaldi, M. Boscaro, Adrenal incidentaloma. Best Pract. Res. Clin. Endocrinol. Metab. 26, 405–419 (2012). https://​doi.​org/​10.​1016/​j.​beem.​2011.​12.​006CrossRefPubMed

go back to reference M. Terzolo, F. Daffara, A. Ardito, B. Zaggia, V. Basile, L. Ferrari, A. Berruti, J. Management of adrenal cancer: a 2013 update. Endocrinol. Invest 37, 207–217 (2014). https://doi.org/10.1007/s40618-013-0049-2CrossRef M. Terzolo, F. Daffara, A. Ardito, B. Zaggia, V. Basile, L. Ferrari, A. Berruti, J. Management of adrenal cancer: a 2013 update. Endocrinol. Invest 37, 207–217 (2014). https://​doi.​org/​10.​1007/​s40618-013-0049-2CrossRef

go back to reference R. Libé, I. Borget, C.L. Ronchi, B. Zaggia, M. Kroiss, T. Kerkhofs, J. Bertherat, M. Volante, M. Quinkler, O. Chabre, M. Bala, A. Tabarin, F. Beuschlein, D. Vezzosi, T. Deutschbein, F. Borson-Chazot, I. Hermsen, A. Stell, C. Fottner, S. Leboulleux, S. Hahner, M. Mannelli, A. Berruti, H. Haak, M. Terzolo, M. Fassnacht, E. Baudin; ENSAT network, Prognostic factors in stage III–IV adrenocortical carcinomas (ACC): an European Network for the Study of Adrenal Tumor (ENSAT) study. Ann. Oncol. 26, 2119–2125 (2015). https://doi.org/10.1093/annonc/mdv329CrossRefPubMed R. Libé, I. Borget, C.L. Ronchi, B. Zaggia, M. Kroiss, T. Kerkhofs, J. Bertherat, M. Volante, M. Quinkler, O. Chabre, M. Bala, A. Tabarin, F. Beuschlein, D. Vezzosi, T. Deutschbein, F. Borson-Chazot, I. Hermsen, A. Stell, C. Fottner, S. Leboulleux, S. Hahner, M. Mannelli, A. Berruti, H. Haak, M. Terzolo, M. Fassnacht, E. Baudin; ENSAT network, Prognostic factors in stage III–IV adrenocortical carcinomas (ACC): an European Network for the Study of Adrenal Tumor (ENSAT) study. Ann. Oncol. 26, 2119–2125 (2015). https://​doi.​org/​10.​1093/​annonc/​mdv329CrossRefPubMed

go back to reference M. Fassnacht, O.M. Dekkers, T. Else, E. Baudin, A. Berruti, R.R. De Krijger, H.R. Haak, R. Mihai, G. Assie, M. Terzolo, European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors. Eur. J. Endocrinol 179, G1–G46 (2018). https://doi.org/10.1530/EJE-18-0608CrossRefPubMed M. Fassnacht, O.M. Dekkers, T. Else, E. Baudin, A. Berruti, R.R. De Krijger, H.R. Haak, R. Mihai, G. Assie, M. Terzolo, European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors. Eur. J. Endocrinol 179, G1–G46 (2018). https://​doi.​org/​10.​1530/​EJE-18-0608CrossRefPubMed

go back to reference K. Pantel, C. Alix-Panabières, Real-time liquid biopsy in cancer patients: fact or fiction? Cancer Res. 73, 6384–6388 (2013). https://doi.org/10.1158/0008-5472.CAN-13-2030CrossRefPubMed K. Pantel, C. Alix-Panabières, Real-time liquid biopsy in cancer patients: fact or fiction? Cancer Res. 73, 6384–6388 (2013). https://​doi.​org/​10.​1158/​0008-5472.​CAN-13-2030CrossRefPubMed

go back to reference E. Crowley, F. Di Nicolantonio, F. Loupakis, A. Bardelli, Liquid biopsy: monitoring cancer-genetics in the blood. Nat. Rev. Clin. Oncol. 10, 472–484 (2013). https://doi.org/10.1038/NRCLINONC.2013.110CrossRefPubMed E. Crowley, F. Di Nicolantonio, F. Loupakis, A. Bardelli, Liquid biopsy: monitoring cancer-genetics in the blood. Nat. Rev. Clin. Oncol. 10, 472–484 (2013). https://​doi.​org/​10.​1038/​NRCLINONC.​2013.​110CrossRefPubMed

go back to reference C. Alix-Panabières, K. Pantel, Clinical applications of circulating tumor cells and circulating tumor dna as liquid biopsy. Cancer Discov. 6, 479–491 (2016). https://doi.org/10.1158/2159-8290.CD-15-1483CrossRefPubMed C. Alix-Panabières, K. Pantel, Clinical applications of circulating tumor cells and circulating tumor dna as liquid biopsy. Cancer Discov. 6, 479–491 (2016). https://​doi.​org/​10.​1158/​2159-8290.​CD-15-1483CrossRefPubMed

go back to reference W. Zhang, W. Xia, Z. Lv, C. Ni, Y. Xin, L. Yang, Liquid Biopsy for Cancer: Circulating Tumor Cells, Circulating Free DNA or Exosomes? Cell. Physiol. Biochem. 41, 755–768 (2017). https://doi.org/10.1159/000458736CrossRefPubMed W. Zhang, W. Xia, Z. Lv, C. Ni, Y. Xin, L. Yang, Liquid Biopsy for Cancer: Circulating Tumor Cells, Circulating Free DNA or Exosomes? Cell. Physiol. Biochem. 41, 755–768 (2017). https://​doi.​org/​10.​1159/​000458736CrossRefPubMed

go back to reference M. Russano, A. Napolitano, G. Ribelli, M. Iuliani, S. Simonetti, F. Citarella, F. Pantano, E. Dell’aquila, C. Anesi, N. Silvestris, A. Argentiero, A. Solimando, B. Vincenzi, G. Tonini, D. Santini, Liquid biopsy and tumor heterogeneity in metastatic solid tumors: the potentiality of blood samples. J. Exp. Clin. Cancer Res. 39, (2020). https://doi.org/10.1186/s13046-020-01601-2. M. Russano, A. Napolitano, G. Ribelli, M. Iuliani, S. Simonetti, F. Citarella, F. Pantano, E. Dell’aquila, C. Anesi, N. Silvestris, A. Argentiero, A. Solimando, B. Vincenzi, G. Tonini, D. Santini, Liquid biopsy and tumor heterogeneity in metastatic solid tumors: the potentiality of blood samples. J. Exp. Clin. Cancer Res. 39, (2020). https://​doi.​org/​10.​1186/​s13046-020-01601-2.

go back to reference M. Cristofanilli, G.T. Budd, M.J. Ellis, A. Stopeck, J. Matera, M.C. Miller, J.M. Reuben, G.V. Doyle, W.J. Allard, L.W.M.M. Terstappen, D.F. Hayes, Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N. Engl. J. Med. 351, 781–791 (2004). https://doi.org/10.1056/NEJMOA040766CrossRefPubMed M. Cristofanilli, G.T. Budd, M.J. Ellis, A. Stopeck, J. Matera, M.C. Miller, J.M. Reuben, G.V. Doyle, W.J. Allard, L.W.M.M. Terstappen, D.F. Hayes, Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N. Engl. J. Med. 351, 781–791 (2004). https://​doi.​org/​10.​1056/​NEJMOA040766CrossRefPubMed

go back to reference Y.F. Sun, X.R. Yang, J. Zhou, S.J. Qiu, J. Fan, Y. Xu, Circulating tumor cells: advances in detection methods, biological issues, and clinical relevance. J. Cancer Res. Clin. Oncol. 137, 1151–1173 (2011). https://doi.org/10.1007/S00432-011-0988-YCrossRefPubMed Y.F. Sun, X.R. Yang, J. Zhou, S.J. Qiu, J. Fan, Y. Xu, Circulating tumor cells: advances in detection methods, biological issues, and clinical relevance. J. Cancer Res. Clin. Oncol. 137, 1151–1173 (2011). https://​doi.​org/​10.​1007/​S00432-011-0988-YCrossRefPubMed

go back to reference W.J. Allard, J. Matera, M.C. Miller, M. Repollet, M.C. Connelly, C. Rao, A.G.J. Tibbe, J.W. Uhr, L.W.M.M. Terstappen, Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin. Cancer Res. 10, 6897–6904 (2004). https://doi.org/10.1158/1078-0432.CCR-04-0378CrossRefPubMed W.J. Allard, J. Matera, M.C. Miller, M. Repollet, M.C. Connelly, C. Rao, A.G.J. Tibbe, J.W. Uhr, L.W.M.M. Terstappen, Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin. Cancer Res. 10, 6897–6904 (2004). https://​doi.​org/​10.​1158/​1078-0432.​CCR-04-0378CrossRefPubMed

go back to reference S. Riethdorf, H. Wikman, K. Pantel, Review: biological relevance of disseminated tumor cells in cancer patients. Int. J. Cancer 123, 1991–2006 (2008). https://doi.org/10.1002/ijc.23825CrossRefPubMed S. Riethdorf, H. Wikman, K. Pantel, Review: biological relevance of disseminated tumor cells in cancer patients. Int. J. Cancer 123, 1991–2006 (2008). https://​doi.​org/​10.​1002/​ijc.​23825CrossRefPubMed

go back to reference K.E. Sundling, A.C. Lowe, Circulating tumor cells: overview and opportunities in cytology. Adv. Anat. Pathol 26, 56–63 (2019). https://doi.org/10.1002/IJC.23825CrossRefPubMed K.E. Sundling, A.C. Lowe, Circulating tumor cells: overview and opportunities in cytology. Adv. Anat. Pathol 26, 56–63 (2019). https://​doi.​org/​10.​1002/​IJC.​23825CrossRefPubMed

go back to reference M. Yu, A. Bardia, B.S. Wittner, S.L. Stott, M.E. Smas, D.T. Ting, S.J. Isakoff, J.C. Ciciliano, M.N. Wells, A.M. Shah, K.F. Concannon, M.C. Donaldson, L.V. Sequist, E. Brachtel, D. Sgroi, J. Baselga, S. Ramaswamy, M. Toner, D.A. Haber, S. Maheswaran, Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition. Science 339, 580–584 (2013). https://doi.org/10.1126/SCIENCE.1228522CrossRefPubMedPubMedCentral M. Yu, A. Bardia, B.S. Wittner, S.L. Stott, M.E. Smas, D.T. Ting, S.J. Isakoff, J.C. Ciciliano, M.N. Wells, A.M. Shah, K.F. Concannon, M.C. Donaldson, L.V. Sequist, E. Brachtel, D. Sgroi, J. Baselga, S. Ramaswamy, M. Toner, D.A. Haber, S. Maheswaran, Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition. Science 339, 580–584 (2013). https://​doi.​org/​10.​1126/​SCIENCE.​1228522CrossRefPubMedPubMedCentral

go back to reference A. Satelli, A. Mitra, Z. Brownlee, X. Xia, S. Bellister, M.J. Overman, S. Kopetz, L.M. Ellis, Q.H. Meng, S. Li, Epithelial-mesenchymal transitioned circulating tumor cells capture for detecting tumor progression. Clin. Cancer Res. 21, 899–906 (2015). https://doi.org/10.1158/1078-0432.CCR-14-0894CrossRefPubMed A. Satelli, A. Mitra, Z. Brownlee, X. Xia, S. Bellister, M.J. Overman, S. Kopetz, L.M. Ellis, Q.H. Meng, S. Li, Epithelial-mesenchymal transitioned circulating tumor cells capture for detecting tumor progression. Clin. Cancer Res. 21, 899–906 (2015). https://​doi.​org/​10.​1158/​1078-0432.​CCR-14-0894CrossRefPubMed

go back to reference N. Aceto, A. Bardia, D.T. Miyamoto, M.C. Donaldson, B.S. Wittner, J.A. Spencer, M. Yu, A. Pely, A. Engstrom, H. Zhu, B.W. Brannigan, R. Kapur, S.L. Stott, T. Shioda, S. Ramaswamy, D.T. Ting, C.P. Lin, M. Toner, D.A. Haber, S. Maheswaran, Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis. Cell 158, 1110–1122 (2014). https://doi.org/10.1016/J.CELL.2014.07.013CrossRefPubMedPubMedCentral N. Aceto, A. Bardia, D.T. Miyamoto, M.C. Donaldson, B.S. Wittner, J.A. Spencer, M. Yu, A. Pely, A. Engstrom, H. Zhu, B.W. Brannigan, R. Kapur, S.L. Stott, T. Shioda, S. Ramaswamy, D.T. Ting, C.P. Lin, M. Toner, D.A. Haber, S. Maheswaran, Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis. Cell 158, 1110–1122 (2014). https://​doi.​org/​10.​1016/​J.​CELL.​2014.​07.​013CrossRefPubMedPubMedCentral

go back to reference N. Aceto, M. Toner, S. Maheswaran, D.A. Haber, En route to metastasis: circulating tumor cell clusters and epithelial-to-mesenchymal transition. Trends in Cancer. 1, 44–52 (2015). https://doi.org/10.1016/J.TRECAN.2015.07.006CrossRefPubMed N. Aceto, M. Toner, S. Maheswaran, D.A. Haber, En route to metastasis: circulating tumor cell clusters and epithelial-to-mesenchymal transition. Trends in Cancer. 1, 44–52 (2015). https://​doi.​org/​10.​1016/​J.​TRECAN.​2015.​07.​006CrossRefPubMed

go back to reference K. Kolostova, J. Spicka, R. Matkowski, V. Bobek, Isolation, primary culture, morphological and molecular characterization of circulating tumor cells in gynecological cancers. Am. J. Transl. Res. 7, 1203–1213 (2015)PubMedPubMedCentral K. Kolostova, J. Spicka, R. Matkowski, V. Bobek, Isolation, primary culture, morphological and molecular characterization of circulating tumor cells in gynecological cancers. Am. J. Transl. Res. 7, 1203–1213 (2015)PubMedPubMedCentral

go back to reference S. Maheswaran, D.A. Haber, Ex Vivo Culture of CTCs: An Emerging Resource to Guide Cancer Therapy. Cancer Res. 75, 2411–2415 (2015). https://doi.org/10.1158/0008-5472.CAN-15-0145CrossRefPubMedPubMedCentral S. Maheswaran, D.A. Haber, Ex Vivo Culture of CTCs: An Emerging Resource to Guide Cancer Therapy. Cancer Res. 75, 2411–2415 (2015). https://​doi.​org/​10.​1158/​0008-5472.​CAN-15-0145CrossRefPubMedPubMedCentral

go back to reference P. Pinzani, C. Scatena, F. Salvianti, E. Corsini, L. Canu, G. Poli, M. Paglierani, V. Piccini, M. Pazzagli, G. Nesi, M. Mannelli, M. Luconi, Detection of circulating tumor cells in patients with adrenocortical carcinoma: a monocentric preliminary study. J. Clin. Endocrinol. Metab. 98, 3731–3738 (2013). https://doi.org/10.1210/jc.2013-1396CrossRefPubMed P. Pinzani, C. Scatena, F. Salvianti, E. Corsini, L. Canu, G. Poli, M. Paglierani, V. Piccini, M. Pazzagli, G. Nesi, M. Mannelli, M. Luconi, Detection of circulating tumor cells in patients with adrenocortical carcinoma: a monocentric preliminary study. J. Clin. Endocrinol. Metab. 98, 3731–3738 (2013). https://​doi.​org/​10.​1210/​jc.​2013-1396CrossRefPubMed

go back to reference G. Cantini, L. Canu, R. Armignacco, F. Salvianti, G. De Filpo, T. Ercolino, G. Nesi, M. Maggi, M. Mannelli, P. Pinzani, M. Luconi, Prognostic and Monitoring Value of Circulating Tumor Cells in Adrenocortical Carcinoma: A Preliminary Monocentric Study. Cancers 12, 1–23 (2020). https://doi.org/10.3390/CANCERS12113176CrossRef G. Cantini, L. Canu, R. Armignacco, F. Salvianti, G. De Filpo, T. Ercolino, G. Nesi, M. Maggi, M. Mannelli, P. Pinzani, M. Luconi, Prognostic and Monitoring Value of Circulating Tumor Cells in Adrenocortical Carcinoma: A Preliminary Monocentric Study. Cancers 12, 1–23 (2020). https://​doi.​org/​10.​3390/​CANCERS12113176CrossRef

go back to reference S.A. Leon, B. Shapiro, D.M. Sklaroff, M.J. Yaros, Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res. 37, 646–650 (1977)PubMed S.A. Leon, B. Shapiro, D.M. Sklaroff, M.J. Yaros, Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res. 37, 646–650 (1977)PubMed

go back to reference C. Bettegowda, M. Sausen, R.J. Leary, I. Kinde, Y. Wang, N. Agrawal, B.R. Bartlett, H. Wang, B. Luber, R.M. Alani, E.S. Antonarakis, N.S. Azad, A. Bardelli, H. Brem, J.L. Cameron, C.C. Lee, L.A. Fecher, G.L. Gallia, P. Gibbs, D. Le, R.L. Giuntoli, M. Goggins, M.D. Hogarty, M. Holdhoff, S.M. Hong, Y. Jiao, H.H. Juhl, J.J. Kim, G. Siravegna, D.A. Laheru, C. Lauricella, M. Lim, E.J. Lipson, S.K.N. Marie, G.J. Netto, K.S. Oliner, A. Olivi, L. Olsson, G.J. Riggins, A. Sartore-Bianchi, K. Schmidt, I.M. Shih, S.M. Oba-Shinjo, S. Siena, D. Theodorescu, J. Tie, T.T. Harkins, S. Veronese, T.L. Wang, J.D. Weingart, C.L. Wolfgang, L.D. Wood, D. Xing, R.H. Hruban, J. Wu, P.J. Allen, C.M. Schmidt, M.A. Choti, V.E. Velculescu, K.W. Kinzler, B. Vogelstein, N. Papadopoulos, L.A. Diaz, Detection of circulating tumor DNA in early- and late-stage human malignancies. Sci. Transl. Med. 6, (2014). https://doi.org/10.1126/SCITRANSLMED.3007094. C. Bettegowda, M. Sausen, R.J. Leary, I. Kinde, Y. Wang, N. Agrawal, B.R. Bartlett, H. Wang, B. Luber, R.M. Alani, E.S. Antonarakis, N.S. Azad, A. Bardelli, H. Brem, J.L. Cameron, C.C. Lee, L.A. Fecher, G.L. Gallia, P. Gibbs, D. Le, R.L. Giuntoli, M. Goggins, M.D. Hogarty, M. Holdhoff, S.M. Hong, Y. Jiao, H.H. Juhl, J.J. Kim, G. Siravegna, D.A. Laheru, C. Lauricella, M. Lim, E.J. Lipson, S.K.N. Marie, G.J. Netto, K.S. Oliner, A. Olivi, L. Olsson, G.J. Riggins, A. Sartore-Bianchi, K. Schmidt, I.M. Shih, S.M. Oba-Shinjo, S. Siena, D. Theodorescu, J. Tie, T.T. Harkins, S. Veronese, T.L. Wang, J.D. Weingart, C.L. Wolfgang, L.D. Wood, D. Xing, R.H. Hruban, J. Wu, P.J. Allen, C.M. Schmidt, M.A. Choti, V.E. Velculescu, K.W. Kinzler, B. Vogelstein, N. Papadopoulos, L.A. Diaz, Detection of circulating tumor DNA in early- and late-stage human malignancies. Sci. Transl. Med. 6, (2014). https://​doi.​org/​10.​1126/​SCITRANSLMED.​3007094.

go back to reference F. Diehl, K. Schmidt, M.A. Choti, K. Romans, S. Goodman, M. Li, K. Thornton, N. Agrawal, L. Sokoll, S.A. Szabo, K.W. Kinzler, B. Vogelstein, L.A. Diaz, Circulating mutant DNA to assess tumor dynamics. Nat. Med. 14, 985–990 (2008). https://doi.org/10.1038/NM.1789CrossRefPubMed F. Diehl, K. Schmidt, M.A. Choti, K. Romans, S. Goodman, M. Li, K. Thornton, N. Agrawal, L. Sokoll, S.A. Szabo, K.W. Kinzler, B. Vogelstein, L.A. Diaz, Circulating mutant DNA to assess tumor dynamics. Nat. Med. 14, 985–990 (2008). https://​doi.​org/​10.​1038/​NM.​1789CrossRefPubMed

go back to reference C. Alix-Panabières, H. Schwarzenbach, K. Pantel, Circulating tumor cells and circulating tumor DNA. Annu. Rev. Med. 63, 199–215 (2012). https://doi.org/10.1146/ANNUREV-MED-062310-094219CrossRefPubMed C. Alix-Panabières, H. Schwarzenbach, K. Pantel, Circulating tumor cells and circulating tumor DNA. Annu. Rev. Med. 63, 199–215 (2012). https://​doi.​org/​10.​1146/​ANNUREV-MED-062310-094219CrossRefPubMed

go back to reference C. Fiala, E.P. Diamandis, Utility of circulating tumor DNA in cancer diagnostics with emphasis on early detection. BMC Med. 16, (2018). https://doi.org/10.1186/S12916-018-1157-9. C. Fiala, E.P. Diamandis, Utility of circulating tumor DNA in cancer diagnostics with emphasis on early detection. BMC Med. 16, (2018). https://​doi.​org/​10.​1186/​S12916-018-1157-9.

go back to reference V. Villaflor, B. Won, R. Nagy, K. Banks, R.B. Lanman, A.A. Talasaz, R. Salgia, Biopsy-free circulating tumor DNA assay identifies actionable mutations in lung cancer. Oncotarget 7, 66880–66891 (2016). https://doi.org/10.18632/ONCOTARGET.11801CrossRefPubMedPubMedCentral V. Villaflor, B. Won, R. Nagy, K. Banks, R.B. Lanman, A.A. Talasaz, R. Salgia, Biopsy-free circulating tumor DNA assay identifies actionable mutations in lung cancer. Oncotarget 7, 66880–66891 (2016). https://​doi.​org/​10.​18632/​ONCOTARGET.​11801CrossRefPubMedPubMedCentral

go back to reference C. Abbosh, N.J. Birkbak, G.A. Wilson, M. Jamal-Hanjani, T. Constantin, R. Salari, J. Le Quesne, D.A. Moore, S. Veeriah, R. Rosenthal, T. Marafioti, E. Kirkizlar, T.B.K. Watkins, N. McGranahan, S. Ward, L. Martinson, J. Riley, F. Fraioli, M. Al Bakir, E. Grönroos, F. Zambrana, R. Endozo, W.L. Bi, F.M. Fennessy, N. Sponer, D. Johnson, J. Laycock, S. Shafi, J. Czyzewska-Khan, A. Rowan, T. Chambers, N. Matthews, S. Turajlic, C. Hiley, S.M. Lee, M.D. Forster, T. Ahmad, M. Falzon, E. Borg, D. Lawrence, M. Hayward, S. Kolvekar, N. Panagiotopoulos, S.M. Janes, R. Thakrar, A. Ahmed, F. Blackhall, Y. Summers, D. Hafez, A. Naik, A. Ganguly, S. Kareht, R. Shah, L. Joseph, A.M. Quinn, P.A. Crosbie, B. Naidu, G. Middleton, G. Langman, S. Trotter, M. Nicolson, H. Remmen, K. Kerr, M. Chetty, L. Gomersall, D.A. Fennell, A. Nakas, S. Rathinam, G. Anand, S. Khan, P. Russell, V. Ezhil, B. Ismail, M. Irvin-Sellers, V. Prakash, J.F. Lester, M. Kornaszewska, R. Attanoos, H. Adams, H. Davies, D. Oukrif, A.U. Akarca, J.A. Hartley, H.L. Lowe, S. Lock, N. Iles, H. Bell, Y. Ngai, G. Elgar, Z. Szallasi, R.F. Schwarz, J. Herrero, A. Stewart, S.A. Quezada, K.S. Peggs, P. Van Loo, C. Dive, C.J. Lin, M. Rabinowitz, H.J.W.L. Aerts, A. Hackshaw, J.A. Shaw, B.G. Zimmermann, C. Swanton, L. Bosshard-Carter, G. Goh, P. Gorman, N. Murugaesu, R.E. Hynds, S. Horswell, R. Mitter, M. Escudero, H. Xu, J. Goldman, R.K. Stone, T. Denner, J. Biggs, M. Costa, S. Begum, B. Phillimore, E. Nye, S. Graca, K. Joshi, A. Furness, A. Ben Aissa, Y.N.S. Wong, A. Georgiou, C. Simeon, G. Hector, A. Smith, M. Aranda, M. Novelli, D. Papadatos-Pastos, D. Carnell, R. Mendes, J. George, N. Navani, M. Taylor, J. Choudhary, R. Califano, P. Taylor, P. Krysiak, K. Rammohan, E. Fontaine, R. Booton, M. Evison, S. Moss, F. Idries, P. Bishop, A. Chaturvedi, H. Doran, A. Leek, P. Harrison, R. Waddington, J. Novasio, J. Rogan, E. Smith, J. Tugwood, G. Brady, D.G. Rothwell, F. Chemi, J. Pierce, S. Gulati, M. Bellamy, H. Bancroft, A. Kerr, S. Kadiri, J. Webb, M. Djearaman, A. Thomas, H. Walter, W. Monteiro, H. Marshall, L. Nelson, J. Bennett, L. Primrose, A. Amadi, S. Palmer, J. Miller, K. Buchan, A. Edwards, F. Morgan, A. Verjee, M. MacKenzie, M. Wilcox, S. Smith, N. Gower, C. Ottensmeier, S. Chee, B. Johnson, A. Alzetani, E. Shaw, E. Lim, P. De Sousa, M.T. Barbosa, A. Bowman, S. Jordan, A. Rice, H. Raubenheimer, C. Proli, M.E. Cufari, J.C. Ronquillo, A. Kwayie, H. Bhayani, M. Hamilton, Y. Bakar, N. Mensah, L. Ambrose, A. Devaraj, S. Buderi, J. Finch, L. Azcarate, H. Chavan, S. Green, H. Mashinga, A.G. Nicholson, K. Lau, M. Sheaff, P. Schmid, J. Conibear, T. Light, T. Horey, S. Danson, J. Bury, J. Edwards, J. Hill, S. Matthews, Y. Kitsanta, K. Suvarna, P. Fisher, A.D. Keerio, M. Shackcloth, J. Gosney, P. Postmus, S. Feeney, J. Asante-Siaw, S. Dentro, C. Dessimoz, Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution. Nature 545, 446–451 (2017). https://doi.org/10.1038/nature22364CrossRefPubMedPubMedCentral C. Abbosh, N.J. Birkbak, G.A. Wilson, M. Jamal-Hanjani, T. Constantin, R. Salari, J. Le Quesne, D.A. Moore, S. Veeriah, R. Rosenthal, T. Marafioti, E. Kirkizlar, T.B.K. Watkins, N. McGranahan, S. Ward, L. Martinson, J. Riley, F. Fraioli, M. Al Bakir, E. Grönroos, F. Zambrana, R. Endozo, W.L. Bi, F.M. Fennessy, N. Sponer, D. Johnson, J. Laycock, S. Shafi, J. Czyzewska-Khan, A. Rowan, T. Chambers, N. Matthews, S. Turajlic, C. Hiley, S.M. Lee, M.D. Forster, T. Ahmad, M. Falzon, E. Borg, D. Lawrence, M. Hayward, S. Kolvekar, N. Panagiotopoulos, S.M. Janes, R. Thakrar, A. Ahmed, F. Blackhall, Y. Summers, D. Hafez, A. Naik, A. Ganguly, S. Kareht, R. Shah, L. Joseph, A.M. Quinn, P.A. Crosbie, B. Naidu, G. Middleton, G. Langman, S. Trotter, M. Nicolson, H. Remmen, K. Kerr, M. Chetty, L. Gomersall, D.A. Fennell, A. Nakas, S. Rathinam, G. Anand, S. Khan, P. Russell, V. Ezhil, B. Ismail, M. Irvin-Sellers, V. Prakash, J.F. Lester, M. Kornaszewska, R. Attanoos, H. Adams, H. Davies, D. Oukrif, A.U. Akarca, J.A. Hartley, H.L. Lowe, S. Lock, N. Iles, H. Bell, Y. Ngai, G. Elgar, Z. Szallasi, R.F. Schwarz, J. Herrero, A. Stewart, S.A. Quezada, K.S. Peggs, P. Van Loo, C. Dive, C.J. Lin, M. Rabinowitz, H.J.W.L. Aerts, A. Hackshaw, J.A. Shaw, B.G. Zimmermann, C. Swanton, L. Bosshard-Carter, G. Goh, P. Gorman, N. Murugaesu, R.E. Hynds, S. Horswell, R. Mitter, M. Escudero, H. Xu, J. Goldman, R.K. Stone, T. Denner, J. Biggs, M. Costa, S. Begum, B. Phillimore, E. Nye, S. Graca, K. Joshi, A. Furness, A. Ben Aissa, Y.N.S. Wong, A. Georgiou, C. Simeon, G. Hector, A. Smith, M. Aranda, M. Novelli, D. Papadatos-Pastos, D. Carnell, R. Mendes, J. George, N. Navani, M. Taylor, J. Choudhary, R. Califano, P. Taylor, P. Krysiak, K. Rammohan, E. Fontaine, R. Booton, M. Evison, S. Moss, F. Idries, P. Bishop, A. Chaturvedi, H. Doran, A. Leek, P. Harrison, R. Waddington, J. Novasio, J. Rogan, E. Smith, J. Tugwood, G. Brady, D.G. Rothwell, F. Chemi, J. Pierce, S. Gulati, M. Bellamy, H. Bancroft, A. Kerr, S. Kadiri, J. Webb, M. Djearaman, A. Thomas, H. Walter, W. Monteiro, H. Marshall, L. Nelson, J. Bennett, L. Primrose, A. Amadi, S. Palmer, J. Miller, K. Buchan, A. Edwards, F. Morgan, A. Verjee, M. MacKenzie, M. Wilcox, S. Smith, N. Gower, C. Ottensmeier, S. Chee, B. Johnson, A. Alzetani, E. Shaw, E. Lim, P. De Sousa, M.T. Barbosa, A. Bowman, S. Jordan, A. Rice, H. Raubenheimer, C. Proli, M.E. Cufari, J.C. Ronquillo, A. Kwayie, H. Bhayani, M. Hamilton, Y. Bakar, N. Mensah, L. Ambrose, A. Devaraj, S. Buderi, J. Finch, L. Azcarate, H. Chavan, S. Green, H. Mashinga, A.G. Nicholson, K. Lau, M. Sheaff, P. Schmid, J. Conibear, T. Light, T. Horey, S. Danson, J. Bury, J. Edwards, J. Hill, S. Matthews, Y. Kitsanta, K. Suvarna, P. Fisher, A.D. Keerio, M. Shackcloth, J. Gosney, P. Postmus, S. Feeney, J. Asante-Siaw, S. Dentro, C. Dessimoz, Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution. Nature 545, 446–451 (2017). https://​doi.​org/​10.​1038/​nature22364CrossRefPubMedPubMedCentral

go back to reference T. Forshew, M. Murtaza, C. Parkinson, D. Gale, D.W.Y. Tsui, F. Kaper, S.J. Dawson, A.M. Piskorz, M. Jimenez-Linan, D. Bentley, J. Hadfield, A.P. May, C. Caldas, J.D. Brenton, and N. Rosenfeld, Noninvasive identification and monitoring of cancer mutations by targeted deep sequencing of plasma DNA. Sci. Transl. Med. 4, (2012). https://doi.org/10.1126/SCITRANSLMED.3003726. T. Forshew, M. Murtaza, C. Parkinson, D. Gale, D.W.Y. Tsui, F. Kaper, S.J. Dawson, A.M. Piskorz, M. Jimenez-Linan, D. Bentley, J. Hadfield, A.P. May, C. Caldas, J.D. Brenton, and N. Rosenfeld, Noninvasive identification and monitoring of cancer mutations by targeted deep sequencing of plasma DNA. Sci. Transl. Med. 4, (2012). https://​doi.​org/​10.​1126/​SCITRANSLMED.​3003726.

go back to reference H.H. Popper, Commentary on tumor heterogeneity. Transl. Lung Cancer Res. 5, 433–435 (2016). https://doi.org/10.21037/TLCR.2016.08.07CrossRefPubMedPubMedCentral H.H. Popper, Commentary on tumor heterogeneity. Transl. Lung Cancer Res. 5, 433–435 (2016). https://​doi.​org/​10.​21037/​TLCR.​2016.​08.​07CrossRefPubMedPubMedCentral

go back to reference S. Cristiano, A. Leal, J. Phallen, J. Fiksel, V. Adleff, D.C. Bruhm, S.Ø. Jensen, J.E. Medina, C. Hruban, J.R. White, D.N. Palsgrove, N. Niknafs, V. Anagnostou, P. Forde, J. Naidoo, K. Marrone, J. Brahmer, B.D. Woodward, H. Husain, K.L. van Rooijen, M.B.W. Ørntoft, A.H. Madsen, C.J.H. van de Velde, M. Verheij, A. Cats, C.J.A. Punt, G.R. Vink, N.C.T. van Grieken, M. Koopman, R.J.A. Fijneman, J.S. Johansen, H.J. Nielsen, G.A. Meijer, C.L. Andersen, R.B. Scharpf, V.E. Velculescu, Genome-wide cell-free DNA fragmentation in patients with cancer. Nature 570, 385–389 (2019). https://doi.org/10.1038/S41586-019-1272-6CrossRefPubMedPubMedCentral S. Cristiano, A. Leal, J. Phallen, J. Fiksel, V. Adleff, D.C. Bruhm, S.Ø. Jensen, J.E. Medina, C. Hruban, J.R. White, D.N. Palsgrove, N. Niknafs, V. Anagnostou, P. Forde, J. Naidoo, K. Marrone, J. Brahmer, B.D. Woodward, H. Husain, K.L. van Rooijen, M.B.W. Ørntoft, A.H. Madsen, C.J.H. van de Velde, M. Verheij, A. Cats, C.J.A. Punt, G.R. Vink, N.C.T. van Grieken, M. Koopman, R.J.A. Fijneman, J.S. Johansen, H.J. Nielsen, G.A. Meijer, C.L. Andersen, R.B. Scharpf, V.E. Velculescu, Genome-wide cell-free DNA fragmentation in patients with cancer. Nature 570, 385–389 (2019). https://​doi.​org/​10.​1038/​S41586-019-1272-6CrossRefPubMedPubMedCentral

go back to reference A. Dasari, V.K. Morris, C.J. Allegra, C. Atreya, A.B. Benson, P. Boland, K. Chung, M.S. Copur, R.B. Corcoran, D.A. Deming, A. Dwyer, M. Diehn, C. Eng, T.J. George, M.J. Gollub, R.A. Goodwin, S.R. Hamilton, J.F. Hechtman, H. Hochster, T.S. Hong, F. Innocenti, A. Iqbal, S.A. Jacobs, H.F. Kennecke, J.J. Lee, C.H. Lieu, H.J. Lenz, O.W. Lindwasser, C. Montagut, B. Odisio, F.S. Ou, L. Porter, K. Raghav, D. Schrag, A.J. Scott, Q. Shi, J.H. Strickler, A. Venook, R. Yaeger, G. Yothers, Y.N. You, J.A. Zell, S. Kopetz, ctDNA applications and integration in colorectal cancer: an NCI Colon and Rectal-Anal Task Forces whitepaper. Nat. Rev. Clin. Oncol. 17, 757–770 (2020). https://doi.org/10.1038/S41571-020-0392-0CrossRefPubMedPubMedCentral A. Dasari, V.K. Morris, C.J. Allegra, C. Atreya, A.B. Benson, P. Boland, K. Chung, M.S. Copur, R.B. Corcoran, D.A. Deming, A. Dwyer, M. Diehn, C. Eng, T.J. George, M.J. Gollub, R.A. Goodwin, S.R. Hamilton, J.F. Hechtman, H. Hochster, T.S. Hong, F. Innocenti, A. Iqbal, S.A. Jacobs, H.F. Kennecke, J.J. Lee, C.H. Lieu, H.J. Lenz, O.W. Lindwasser, C. Montagut, B. Odisio, F.S. Ou, L. Porter, K. Raghav, D. Schrag, A.J. Scott, Q. Shi, J.H. Strickler, A. Venook, R. Yaeger, G. Yothers, Y.N. You, J.A. Zell, S. Kopetz, ctDNA applications and integration in colorectal cancer: an NCI Colon and Rectal-Anal Task Forces whitepaper. Nat. Rev. Clin. Oncol. 17, 757–770 (2020). https://​doi.​org/​10.​1038/​S41571-020-0392-0CrossRefPubMedPubMedCentral

go back to reference K. Tóth, B.K. Barták, Z. Tulassay, B. Molnár, Circulating cell-free nucleic acids as biomarkers in colorectal cancer screening and diagnosis. Expert Rev. Mol. Diagn. 16, 239–252 (2016). https://doi.org/10.1586/14737159.2016.1132164CrossRefPubMed K. Tóth, B.K. Barták, Z. Tulassay, B. Molnár, Circulating cell-free nucleic acids as biomarkers in colorectal cancer screening and diagnosis. Expert Rev. Mol. Diagn. 16, 239–252 (2016). https://​doi.​org/​10.​1586/​14737159.​2016.​1132164CrossRefPubMed

go back to reference B. Molnár, O. Galamb, A. Kalmár, B.K. Barták, Z.B. Nagy, K. Tóth, Z. Tulassay, P. Igaz, M. Dank, Circulating cell-free nucleic acids as biomarkers in colorectal cancer screening and diagnosis - an update. Expert Rev. Mol. Diagn. 19, 477–498 (2019). https://doi.org/10.1080/14737159.2019.1613891CrossRefPubMed B. Molnár, O. Galamb, A. Kalmár, B.K. Barták, Z.B. Nagy, K. Tóth, Z. Tulassay, P. Igaz, M. Dank, Circulating cell-free nucleic acids as biomarkers in colorectal cancer screening and diagnosis - an update. Expert Rev. Mol. Diagn. 19, 477–498 (2019). https://​doi.​org/​10.​1080/​14737159.​2019.​1613891CrossRefPubMed

go back to reference M.J.M. Magbanua, L.B. Swigart, H.T. Wu, G.L. Hirst, C. Yau, D.M. Wolf, A. Tin, R. Salari, S. Shchegrova, H. Pawar, A.L. Delson, A. DeMichele, M.C. Liu, A.J. Chien, D. Tripathy, S. Asare, C.H.J. Lin, P. Billings, A. Aleshin, H. Sethi, M. Louie, B. Zimmermann, L.J. Esserman, L.J. van ‘t Veer, Circulating tumor DNA in neoadjuvant-treated breast cancer reflects response and survival. Ann. Oncol. Off. J. Eur. Soc. Med. Oncol. 32, 229–239 (2021). https://doi.org/10.1016/J.ANNONC.2020.11.007CrossRef M.J.M. Magbanua, L.B. Swigart, H.T. Wu, G.L. Hirst, C. Yau, D.M. Wolf, A. Tin, R. Salari, S. Shchegrova, H. Pawar, A.L. Delson, A. DeMichele, M.C. Liu, A.J. Chien, D. Tripathy, S. Asare, C.H.J. Lin, P. Billings, A. Aleshin, H. Sethi, M. Louie, B. Zimmermann, L.J. Esserman, L.J. van ‘t Veer, Circulating tumor DNA in neoadjuvant-treated breast cancer reflects response and survival. Ann. Oncol. Off. J. Eur. Soc. Med. Oncol. 32, 229–239 (2021). https://​doi.​org/​10.​1016/​J.​ANNONC.​2020.​11.​007CrossRef

go back to reference Y. Wang, L. Yang, H. Bao, X. Fan, F. Xia, J. Wan, L. Shen, Y. Guan, H. Bao, X. Wu, Y. Xu, Y. Shao, Y. Sun, T. Tong, X. Li, Y. Xu, S. Cai, J. Zhu, Z. Zhang, Utility of ctDNA in predicting response to neoadjuvant chemoradiotherapy and prognosis assessment in locally advanced rectal cancer: A prospective cohort study. PLoS Med. 18, (2021). https://doi.org/10.1371/JOURNAL.PMED.1003741. Y. Wang, L. Yang, H. Bao, X. Fan, F. Xia, J. Wan, L. Shen, Y. Guan, H. Bao, X. Wu, Y. Xu, Y. Shao, Y. Sun, T. Tong, X. Li, Y. Xu, S. Cai, J. Zhu, Z. Zhang, Utility of ctDNA in predicting response to neoadjuvant chemoradiotherapy and prognosis assessment in locally advanced rectal cancer: A prospective cohort study. PLoS Med. 18, (2021). https://​doi.​org/​10.​1371/​JOURNAL.​PMED.​1003741.

go back to reference S.G. Creemers, E. Korpershoek, P.N. Atmodimedjo, W.N.M. Dinjens, P.M. Van Koetsveld, R.A. Feelders, L.J. Hofland, Identification of Mutations in Cell-Free Circulating Tumor DNA in Adrenocortical Carcinoma: A Case Series. J. Clin. Endocrinol. Metab 102, 3611–3615 (2017). https://doi.org/10.1210/JC.2017-00174CrossRefPubMed S.G. Creemers, E. Korpershoek, P.N. Atmodimedjo, W.N.M. Dinjens, P.M. Van Koetsveld, R.A. Feelders, L.J. Hofland, Identification of Mutations in Cell-Free Circulating Tumor DNA in Adrenocortical Carcinoma: A Case Series. J. Clin. Endocrinol. Metab 102, 3611–3615 (2017). https://​doi.​org/​10.​1210/​JC.​2017-00174CrossRefPubMed

go back to reference S. Garinet, J. Nectoux, M. Neou, E. Pasmant, A. Jouinot, M. Sibony, L. Orhant, J.P. Da Fonseca, K. Perlemoine, L. Bricaire, L. Groussin, O. Soubrane, B. Dousset, R. Libe, F. Letourneur, J. Bertherat, G. Assié, Detection and monitoring of circulating tumor DNA in adrenocortical carcinoma. Endocr. Relat. Cancer 25, L13–L17 (2018). https://doi.org/10.1530/ERC-17-0467CrossRefPubMed S. Garinet, J. Nectoux, M. Neou, E. Pasmant, A. Jouinot, M. Sibony, L. Orhant, J.P. Da Fonseca, K. Perlemoine, L. Bricaire, L. Groussin, O. Soubrane, B. Dousset, R. Libe, F. Letourneur, J. Bertherat, G. Assié, Detection and monitoring of circulating tumor DNA in adrenocortical carcinoma. Endocr. Relat. Cancer 25, L13–L17 (2018). https://​doi.​org/​10.​1530/​ERC-17-0467CrossRefPubMed

go back to reference M.J. McCabe, M. Pinese, C.L. Chan, N. Sheriff, T.J. Thompson, J. Grady, M. Wong, M.E.A. Gauthier, C. Puttick, V. Gayevskiy, E. Hajdu, S.Q. Wong, W. Barrett, P. Earls, R. Lukeis, Y.Y. Cheng, R.C.Y. Lin, D.M. Thomas, D.N. Watkins, M.E. Dinger, A.I. McCormack, M.J. Cowley, Genomic stratification and liquid biopsy in a rare adrenocortical carcinoma (ACC) case, with dual lung metastases Cold Spring Harb. Mol. Case Stud. 5, (2019). https://doi.org/10.1101/mcs.a003764. M.J. McCabe, M. Pinese, C.L. Chan, N. Sheriff, T.J. Thompson, J. Grady, M. Wong, M.E.A. Gauthier, C. Puttick, V. Gayevskiy, E. Hajdu, S.Q. Wong, W. Barrett, P. Earls, R. Lukeis, Y.Y. Cheng, R.C.Y. Lin, D.M. Thomas, D.N. Watkins, M.E. Dinger, A.I. McCormack, M.J. Cowley, Genomic stratification and liquid biopsy in a rare adrenocortical carcinoma (ACC) case, with dual lung metastases Cold Spring Harb. Mol. Case Stud. 5, (2019). https://​doi.​org/​10.​1101/​mcs.​a003764.

go back to reference D.P. Bartel, MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281–297 (2004). https://doi.org/10.1016/s0092-8674(04)00045-5CrossRefPubMed D.P. Bartel, MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281–297 (2004). https://​doi.​org/​10.​1016/​s0092-8674(04)00045-5CrossRefPubMed

go back to reference J.A. Weber, D.H. Baxter, S. Zhang, D.Y. Huang, K.H. Huang, M.J. Lee, D.J. Galas, K. Wang, The microRNA spectrum in 12 body fluids.Clin. Chem. 56, 1733–1741 (2010). https://doi.org/10.1373/clinchem.2010.147405CrossRefPubMedPubMedCentral J.A. Weber, D.H. Baxter, S. Zhang, D.Y. Huang, K.H. Huang, M.J. Lee, D.J. Galas, K. Wang, The microRNA spectrum in 12 body fluids.Clin. Chem. 56, 1733–1741 (2010). https://​doi.​org/​10.​1373/​clinchem.​2010.​147405CrossRefPubMedPubMedCentral

go back to reference X. Chen, Y. Ba, L. Ma, X. Cai, Y. Yin, K. Wang, J. Guo, Y. Zhang, J. Chen, X. Guo, Q. Li, X. Li, W. Wang, Y. Zhang, J. Wang, X. Jiang, Y. Xiang, C. Xu, P. Zheng, J. Zhang, R. Li, H. Zhang, X. Shang, T. Gong, G. Ning, J. Wang, K. Zen, J. Zhang, C.-Y. Zhang, Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res. 18, 997–1006 (2008). https://doi.org/10.1038/cr.2008.282CrossRefPubMed X. Chen, Y. Ba, L. Ma, X. Cai, Y. Yin, K. Wang, J. Guo, Y. Zhang, J. Chen, X. Guo, Q. Li, X. Li, W. Wang, Y. Zhang, J. Wang, X. Jiang, Y. Xiang, C. Xu, P. Zheng, J. Zhang, R. Li, H. Zhang, X. Shang, T. Gong, G. Ning, J. Wang, K. Zen, J. Zhang, C.-Y. Zhang, Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res. 18, 997–1006 (2008). https://​doi.​org/​10.​1038/​cr.​2008.​282CrossRefPubMed

go back to reference P.S. Mitchell, R.K. Parkin, E.M. Kroh, B.R. Fritz, S.K. Wyman, E.L. Pogosova-Agadjanyan, A. Peterson, J. Noteboom, K.C. O’Briant, A. Allen, D.W. Lin, N. Urban, C.W. Drescher, B.S. Knudsen, D.L. Stirewalt, R. Gentleman, R.L. Vessella, P.S. Nelson, D.B. Martin, M. Tewari, Circulating microRNAs as stable blood-based markers for cancer detection. Proc. Natl. Acad. Sci. U. S. A 105, 10513–10518 (2008). https://doi.org/10.1073/pnas.0804549105.CrossRefPubMedPubMedCentral P.S. Mitchell, R.K. Parkin, E.M. Kroh, B.R. Fritz, S.K. Wyman, E.L. Pogosova-Agadjanyan, A. Peterson, J. Noteboom, K.C. O’Briant, A. Allen, D.W. Lin, N. Urban, C.W. Drescher, B.S. Knudsen, D.L. Stirewalt, R. Gentleman, R.L. Vessella, P.S. Nelson, D.B. Martin, M. Tewari, Circulating microRNAs as stable blood-based markers for cancer detection. Proc. Natl. Acad. Sci. U. S. A 105, 10513–10518 (2008). https://​doi.​org/​10.​1073/​pnas.​0804549105.​CrossRefPubMedPubMedCentral

go back to reference I. Igaz, P. Igaz, Diagnostic Relevance of microRNAs in Other Body Fluids Including Urine, Feces, and Saliva. In Exp. Suppl. 245–252 (2015). https://doi.org/10.1007/978-3-0348-0955-9_11. I. Igaz, P. Igaz, Diagnostic Relevance of microRNAs in Other Body Fluids Including Urine, Feces, and Saliva. In Exp. Suppl. 245–252 (2015). https://​doi.​org/​10.​1007/​978-3-0348-0955-9_​11.

go back to reference I. Igaz, P. Igaz, Tumor surveillance by circulating microRNAs: a hypothesis. Cell. Mol. Life Sci. 71, 4081–4087 (2014). https://doi.org/10.1007/s00018-014-1682-4CrossRefPubMedPubMedCentral I. Igaz, P. Igaz, Tumor surveillance by circulating microRNAs: a hypothesis. Cell. Mol. Life Sci. 71, 4081–4087 (2014). https://​doi.​org/​10.​1007/​s00018-014-1682-4CrossRefPubMedPubMedCentral

go back to reference J.S. McDonald, D. Milosevic, H.V. Reddi, S.K. Grebe, A. Algeciras-Schimnich, Analysis of circulating microRNA: preanalytical and analytical challenges. Clin. Chem. 57, 833–840 (2011). https://doi.org/10.1373/clinchem.2010.157198CrossRefPubMed J.S. McDonald, D. Milosevic, H.V. Reddi, S.K. Grebe, A. Algeciras-Schimnich, Analysis of circulating microRNA: preanalytical and analytical challenges. Clin. Chem. 57, 833–840 (2011). https://​doi.​org/​10.​1373/​clinchem.​2010.​157198CrossRefPubMed

go back to reference K. Page, D.S. Guttery, N. Zahra, L. Primrose, S.R. Elshaw, J.H. Pringle, K. Blighe, S.D. Marchese, A. Hills, L. Woodley, J. Stebbing, R.C. Coombes, J.A. Shaw, Influence of Plasma Processing on Recovery and Analysis of Circulating Nucleic Acids. PLoS One 8, e77963 (2013). https://doi.org/10.1371/journal.pone.0077963CrossRefPubMedPubMedCentral K. Page, D.S. Guttery, N. Zahra, L. Primrose, S.R. Elshaw, J.H. Pringle, K. Blighe, S.D. Marchese, A. Hills, L. Woodley, J. Stebbing, R.C. Coombes, J.A. Shaw, Influence of Plasma Processing on Recovery and Analysis of Circulating Nucleic Acids. PLoS One 8, e77963 (2013). https://​doi.​org/​10.​1371/​journal.​pone.​0077963CrossRefPubMedPubMedCentral

go back to reference P. Igaz, Circulating microRNAs in adrenal tumors. Curr. Opin. Endocrinol. Diabetes Obes. 26, 155–159 (2019). https://doi.org/10.1097/MED.0000000000000472CrossRefPubMed P. Igaz, Circulating microRNAs in adrenal tumors. Curr. Opin. Endocrinol. Diabetes Obes. 26, 155–159 (2019). https://​doi.​org/​10.​1097/​MED.​0000000000000472​CrossRefPubMed

go back to reference A. Decmann, P. Perge, P.I. Turai, A. Patócs, P. Igaz, Non-Coding RNAs in Adrenocortical Cancer: From Pathogenesis to Diagnosis. Cancers. 12, (2020). https://doi.org/10.3390/CANCERS12020461. A. Decmann, P. Perge, P.I. Turai, A. Patócs, P. Igaz, Non-Coding RNAs in Adrenocortical Cancer: From Pathogenesis to Diagnosis. Cancers. 12, (2020). https://​doi.​org/​10.​3390/​CANCERS12020461.

go back to reference O. Chabre, R. Libé, G. Assie, O. Barreau, J. Bertherat, X. Bertagna, J.J. Feige, N. Cherradi, Serum miR-483-5p and miR-195 are predictive of recurrence risk in adrenocortical cancer patients. Endocr. Relat. Cancer 20, 579–594 (2013). https://doi.org/10.1530/ERC-13-0051CrossRefPubMed O. Chabre, R. Libé, G. Assie, O. Barreau, J. Bertherat, X. Bertagna, J.J. Feige, N. Cherradi, Serum miR-483-5p and miR-195 are predictive of recurrence risk in adrenocortical cancer patients. Endocr. Relat. Cancer 20, 579–594 (2013). https://​doi.​org/​10.​1530/​ERC-13-0051CrossRefPubMed

go back to reference P. Perge, H. Butz, R. Pezzani, I. Bancos, Z. Nagy, K. Pálóczi, G. Nyírő, Á. Decmann, E. Pap, M. Luconi, M. Mannelli, E.I. Buzás, M. Tóth, M. Boscaro, A. Patócs, P. Igaz, Evaluation and diagnostic potential of circulating extracellular vesicle-associated microRNAs in adrenocortical tumors. Sci. Rep. 7, 5474 (2017). https://doi.org/10.1038/s41598-017-05777-0CrossRefPubMedPubMedCentral P. Perge, H. Butz, R. Pezzani, I. Bancos, Z. Nagy, K. Pálóczi, G. Nyírő, Á. Decmann, E. Pap, M. Luconi, M. Mannelli, E.I. Buzás, M. Tóth, M. Boscaro, A. Patócs, P. Igaz, Evaluation and diagnostic potential of circulating extracellular vesicle-associated microRNAs in adrenocortical tumors. Sci. Rep. 7, 5474 (2017). https://​doi.​org/​10.​1038/​s41598-017-05777-0CrossRefPubMedPubMedCentral

go back to reference F. Salvianti, L. Canu, G. Poli, R. Armignacco, C. Scatena, G. Cantini, A. Di Franco, S. Gelmini, T. Ercolino, M. Pazzagli, G. Nesi, M. Mannelli, P. Pinzani, M. Luconi, New insights in the clinical and translational relevance of miR483-5p in adrenocortical cancer. Oncotarget 8, 65525–65533 (2017). https://doi.org/10.18632/ONCOTARGET.19118CrossRefPubMedPubMedCentral F. Salvianti, L. Canu, G. Poli, R. Armignacco, C. Scatena, G. Cantini, A. Di Franco, S. Gelmini, T. Ercolino, M. Pazzagli, G. Nesi, M. Mannelli, P. Pinzani, M. Luconi, New insights in the clinical and translational relevance of miR483-5p in adrenocortical cancer. Oncotarget 8, 65525–65533 (2017). https://​doi.​org/​10.​18632/​ONCOTARGET.​19118CrossRefPubMedPubMedCentral

go back to reference M. Oreglia, S. Sbiera, M. Fassnacht, L. Guyon, J. Denis, J. Cristante, O. Chabre, and N. Cherradi, early postoperative circulating mir-483-5p is a prognosis marker for adrenocortical cancer. Cancers. 12, (2020). https://doi.org/10.3390/CANCERS12030724. M. Oreglia, S. Sbiera, M. Fassnacht, L. Guyon, J. Denis, J. Cristante, O. Chabre, and N. Cherradi, early postoperative circulating mir-483-5p is a prognosis marker for adrenocortical cancer. Cancers. 12, (2020). https://​doi.​org/​10.​3390/​CANCERS12030724.

go back to reference Z. Nagy, K. Baghy, É. Hunyadi-Gulyás, T. Micsik, G. Nyírő, G. Rácz, H. Butz, P. Perge, I. Kovalszky, K.F. Medzihradszky, K. Rácz, A. Patócs, P. Igaz, Evaluation of 9-cis retinoic acid and mitotane as antitumoral agents in an adrenocortical xenograft model. Am. J. Cancer Res. 5, 3645–3658 (2015)PubMedPubMedCentral Z. Nagy, K. Baghy, É. Hunyadi-Gulyás, T. Micsik, G. Nyírő, G. Rácz, H. Butz, P. Perge, I. Kovalszky, K.F. Medzihradszky, K. Rácz, A. Patócs, P. Igaz, Evaluation of 9-cis retinoic acid and mitotane as antitumoral agents in an adrenocortical xenograft model. Am. J. Cancer Res. 5, 3645–3658 (2015)PubMedPubMedCentral

go back to reference S. Jung, Z. Nagy, M. Fassnacht, G. Zambetti, M. Weiss, M. Reincke, P. Igaz, F. Beuschlein, C. Hantel, Preclinical progress and first translational steps for a liposomal chemotherapy protocol against adrenocortical carcinoma. Endocr. Relat. Cancer 23, 825–837 (2016). https://doi.org/10.1530/ERC-16-0249CrossRefPubMed S. Jung, Z. Nagy, M. Fassnacht, G. Zambetti, M. Weiss, M. Reincke, P. Igaz, F. Beuschlein, C. Hantel, Preclinical progress and first translational steps for a liposomal chemotherapy protocol against adrenocortical carcinoma. Endocr. Relat. Cancer 23, 825–837 (2016). https://​doi.​org/​10.​1530/​ERC-16-0249CrossRefPubMed

go back to reference G. Huszty, A. Doros, K. Farkas, L. Kóbori, P. Reismann, J. Tőke, M. Tóth, P. Igaz, Case Report: Complete Necrosis of a Large Adrenocortical Cancer and Liver Metastases Achieved by Selective Arterial Embolization: A Case Study and Review of Literature. Front. Endocrinol. 12, (2021). https://doi.org/10.3389/FENDO.2021.677187. G. Huszty, A. Doros, K. Farkas, L. Kóbori, P. Reismann, J. Tőke, M. Tóth, P. Igaz, Case Report: Complete Necrosis of a Large Adrenocortical Cancer and Liver Metastases Achieved by Selective Arterial Embolization: A Case Study and Review of Literature. Front. Endocrinol. 12, (2021). https://​doi.​org/​10.​3389/​FENDO.​2021.​677187.